ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $306,000 | -30.1% | 12,548 | -47.1% | 0.00% | -33.3% |
| Q3 2017 | $438,000 | -18.9% | 23,736 | -27.2% | 0.00% | 0.0% |
| Q2 2017 | $540,000 | +33.3% | 32,594 | +11.0% | 0.00% | +50.0% |
| Q1 2017 | $405,000 | -13.3% | 29,359 | +19.2% | 0.00% | -33.3% |
| Q4 2016 | $467,000 | -14.5% | 24,638 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $546,000 | +53.4% | 24,638 | +26.5% | 0.00% | +50.0% |
| Q2 2016 | $356,000 | +0.6% | 19,481 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $354,000 | +7.9% | 19,481 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $328,000 | +36.1% | 19,481 | +45.4% | 0.00% | 0.0% |
| Q3 2015 | $241,000 | -7.7% | 13,396 | +32.6% | 0.00% | 0.0% |
| Q2 2015 | $261,000 | – | 10,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |